Autolus Therapeutics plc (AUTL)
NASDAQ: AUTL · Real-Time Price · USD
1.370
-0.020 (-1.44%)
At close: Nov 26, 2025, 4:00 PM EST
1.360
-0.010 (-0.73%)
After-hours: Nov 26, 2025, 7:59 PM EST

Autolus Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
3656251,120329378468
Upgrade
Market Cap Growth
-63.26%-44.17%240.67%-13.12%-19.06%-21.26%
Upgrade
Enterprise Value
3222691,057233227343
Upgrade
Last Close Price
1.372.356.441.905.198.94
Upgrade
PS Ratio
7.1361.80659.6951.70162.43272.63
Upgrade
PB Ratio
1.371.4610.051.101.212.23
Upgrade
P/TBV Ratio
1.491.5110.051.101.212.23
Upgrade
EV/Sales Ratio
6.3126.63622.4836.6997.51199.84
Upgrade
Debt / Equity Ratio
1.230.702.010.500.220.26
Upgrade
Asset Turnover
0.070.020.000.010.010.01
Upgrade
Quick Ratio
5.5210.485.908.8711.795.44
Upgrade
Current Ratio
6.1910.886.159.1812.155.86
Upgrade
Return on Equity (ROE)
-60.56%-81.91%-101.61%-48.64%-54.30%-61.13%
Upgrade
Return on Assets (ROA)
-22.99%-25.99%-25.35%-19.94%-25.07%-35.16%
Upgrade
Return on Capital (ROIC)
-25.02%-28.40%-27.98%-21.52%-27.18%-38.55%
Upgrade
Return on Capital Employed (ROCE)
-47.30%-33.40%-53.10%-32.20%-37.20%-64.50%
Upgrade
Earnings Yield
-61.65%-35.28%-18.60%-45.27%-37.55%-30.39%
Upgrade
FCF Yield
-78.22%-36.51%-13.98%-37.45%-33.48%-28.33%
Upgrade
Buyback Yield / Dilution
-14.65%-46.69%-83.11%-31.78%-39.81%-19.72%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q